Wednesday, November 18, 2009

New Balance Men's MW558 Walking Shoe


Product Description

New Balance Men's 558 Walking Shoes offer great mileage with performance cushioning This walking shoe from New Balance features a C-Cap® compression molded EVA midsole that creates superior shock absorption and flexibility, while the Walking Strike Path® outsole controls and stabilizes feet through the walking gait cycle. Feet stay cool and dry in the lightweight, breathable synthetic leather and mesh upper with reflective detailing. This walker has it all! Click here to view the outsole with Walking Strike Path® that stabilizes and guides the foot through the walking gait cycle.

Product Details

* Amazon Sales Rank: #235 in Sports & Outdoors
* Size: *
* Color: *
* Brand: New Balance
* Fabric type: leather
* Number of items: 1

Features

* ABZORB provides a superior blend of cushioning and compression set features with Dupont Engage and Isoprene rubber for the ultimate ride
* WALKING STRIKE PATH Outsole feature that stabilizes and guides the foot through the walking gait cycle
* Ndurance is a rubber compound for maximum durability used in high wear areas


Amazon.com Product Description
An update from the 557, this walking shoe from New Balance will provide long-lasting and long-wearing comfort. It has the classic good looks that you rely on from New Balance, and has all of the comfort technology you could ever want in a casual walking shoe.

Customer Reviews

Nice Shoes4
I recently had foot surgery and have used these shoes to start walking again. The shoes give me the required fit and support. I am fully satisfied.


Best Dad Present!5
I gave these to my "needs exercise" father as a subtle hint to help get him motivated. Well, they haven't quite worked that miracle but they havent left his feet. He just loves them, and this man hates tennis shoes and everything about them. He wears these everywhere these days and sings my praises all the time for giving these to him. The sizing is perfect and they look just like the picture.

No comments:

Post a Comment